Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Biotherapeutics

Tudor Arvinte's Biography

Tudor Arvinte, Chairman and CEO, Therapeomics Inc/University of Geneva

Tudor Arvinte, Ph.D., received his academic training in physics at the University of Jassy, Romania, and his Ph.D. in biophysics from the University of Düsseldorf, Germany. He performed his doctoral work and postdoctoral stage at the Max-Planck-Institute West Germany and held numerous research positions in Europe and the USA. In 1989 he joined Ciba-Geigy Pharmaceuticals in Horsham, England, and in 1994 he moved to Ciba-Geigy in Basel, Switzerland. Until 2002 he worked as Head of Exploratory Formulation, Novartis Biotechnology Development & Production, Basel. T. Arvinte worked on the characterization and formulation of about 80 protein and peptide drugs. T. Arvinte has over 80 publications and holds 13 patents on formulations of proteins. Since 2001 he is Invited Professor at the School of Pharmacy, University of Geneva. T. Arvinte is also Visiting Professor at the Department of Pharmacy, School of Health and Life Sciences King’s College London, UK. In 2003 T. Arvinte co-founded Therapeomic, Inc., a biotech company focused on developing formulations for biopharmaceuticals in collaborations with pharmaceutical companies.

Tudor Arvinte Image

Importance of Formulation for the Success of Biotherapeutics

Wednesday, 27 June 2012 at 09:30

Add to Calendar ▼2012-06-27 09:30:002012-06-27 10:30:00Europe/LondonImportance of Formulation for the Success of

The talk will present case studies documenting the importance of formulation for the proof-of-concept of new biopharmaceutics as well as for the success of clinical trials and market launch. 

Add to Calendar ▼2012-06-27 00:00:002012-06-28 00:00:00Europe/